Preparation method and application of rhabdovirus expressed swine fever E2 subunit vaccine

A subunit vaccine and baculovirus technology, which is applied in the field of preparation of swine fever E2 subunit vaccine, can solve the problems of not being able to prevent and control swine fever, and can not distinguish between infected and immunized animals, and achieve good safety and immunogenicity Strong, high-yielding effect

Active Publication Date: 2019-01-11
ZHEJIANG UNIV
View PDF18 Cites 10 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0003] At present, vaccination is still an important measure for the prevention and control of swine fever, but traditional vaccines cannot distinguish between infected and

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Preparation method and application of rhabdovirus expressed swine fever E2 subunit vaccine
  • Preparation method and application of rhabdovirus expressed swine fever E2 subunit vaccine
  • Preparation method and application of rhabdovirus expressed swine fever E2 subunit vaccine

Examples

Experimental program
Comparison scheme
Effect test

Example Embodiment

[0049] Example 1 Expression of Classical Swine Fever SP-E2 Protein

[0050] 1) Amplification of the target gene

[0051] According to Genbank design primers SP-F, SP-R, E2-F, E2-R, first amplified with SP-F, SP-R to obtain the SP signal peptide, and amplified with E2-F, E2-R to obtain the E2 fragment. Then SP and E2 are used as templates, and SP-F and E2-R primers are amplified to obtain the target gene SP-E2 (such as figure 2 Shown).

[0052] 2) Construction of shuttle plasmid

[0053] The pFastBacHTB plasmid was digested with EcoRI and XholⅠ restriction enzymes at 37°C for 2 hours and recovered. The digested vector and the target gene were recombined with homologous recombinase for 30 minutes at 37°C, transformed into Ecoli competent cells, spotted and identified, and positive bacteria were sent Sequencing.

[0054] 3) Acquisition of recombinant bacmid

[0055] Transform the positive plasmid into DH10Bac competent cells, select leukoplakia 48h later, and perform PCR identification w...

Example Embodiment

[0066] Example 2 Preparation and animal immunization experiment of swine fever SP-E2 protein subunit vaccine of the present invention.

[0067] The SP-E2 protein expressed in Example 1 and Seppic 206 water adjuvant were mixed at a ratio of 1:1 at 350 rpm for 10 minutes, and stored at 4°C and protected from light.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention relates to the technical field of molecular biological and animal biological products and aims to provide a rhabdovirus expressed swine fever E2 subunit vaccine. The vaccine is a signalpeptide-containing swine fever SP-E2 protein expressed by a rhabdovirus expression system, wherein the sequence of signal peptide SP is as shown in SEQ ID NO.1 and the nucleotide sequence of expression E2 protein is as shown in SEQ ID NO.2. After a rat is immunized with the SP-E2 subunit vaccine developed by the invention, a specific antibody for swine fever can be generated more efficiently thanQZ14-E2 and HZ08-E2 proteins, and the comprehensive antibody level is far higher than that of QZ14-E2 and HZ08-E2 proteins; after a pig is immunized, the specific antibody can be induced to generate;the vaccine provided by the invention has high yield, strong immunogenicity and high safety; infected and immunized animals can be distinguished through differential diagnosis; swine fever virus can be fundamentally purified.

Description

technical field [0001] The invention belongs to the technical field of molecular biology and veterinary biological products, and in particular relates to a preparation method and application of a swine fever E2 subunit vaccine expressed by baculovirus. Background technique [0002] Classical swine fever (CSF) is a highly contagious and fatal infectious disease of pigs caused by classical swine fever virus (CSFV). The main features are hemorrhage and splenic infarction, which mainly harm domestic pigs and wild boars, and have caused huge economic losses to the pig industry in the world. The epidemic trend of swine fever has changed a lot, showing the coexistence of typical swine fever and atypical swine fever, the coexistence of recessive infection and persistent infection, and the phenomenon of immune failure occurs from time to time. This new and popular form presents new challenges to the swine industry worldwide. [0003] At present, vaccination is still an important me...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): C12N15/866C12N5/10C07K14/18A61K39/187A61P31/14
CPCA61K39/12A61P31/14C12N15/86C07K14/005A61K2039/552C12N2710/14043C12N2770/24334Y02A50/30
Inventor 徐慧玲何放方维焕
Owner ZHEJIANG UNIV
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products